Skip to main contentSkip to navigation
Sirius Investors
Xeno Transplants Corporation

Xeno Transplants Corporation

XENO
OTCHealthcare

Xeno Transplants Corporation (XENO) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Xeno Transplants Corporation's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2007
P/E Ratio
-306.92
Burn Risk
P/B Ratio
102.89
Weak
WeakModerateStrong
Earnings Yield
-0.32%
Yield Gap

Profitability Health

2007
Return on Equity
-33.21%
Weak
WeakModerateStrong
Operating Margin
-
No data
Net Profit Margin
-
No data

Growth Indicators

2007
Revenue Growth
-
No data
Net Income Growth
-174.74%
Weak
WeakModerateStrong
EPS Growth
61.00%
Strong
WeakModerateStrong

Efficiency & Liquidity

2007
Current Ratio
0.15
Weak
WeakModerateStrong
Quick Ratio
0.15
Weak
WeakModerateStrong
Asset Turnover
-
No data
Inventory Turnover
-
No data

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2007
Free Cash Flow Yield
-1.39%
Weak
WeakModerateStrong
EV / Free Cash Flow
-71.67x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.25x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
-1.000
Weak
WeakModerateStrong
Return on Invested Capital
33.21%
Strong
WeakModerateStrong
Cash Conversion Cycle
0.00 days
Strong
WeakModerateStrong

Fortress screener guardrails

2/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for XENO.

View Financial Statements